Advent appoints operating partner for health sector
Advent International has appointed Christian Grenier as operating partner. He will provide advice on investment opportunities in the healthcare and specialty chemical sectors.
Grenier, with 35 years experience in the aforementioned sectors, is currently executive director of BioVision, a global forum on life sciences. He also occupies top executive positions at Laboratoire Delpharm, Urogene SA and Neorphys SAS.
In 2000, Grenier co-founded UroGene, a biotech company that develops medicine for use in the field of urology. Prior to that, he was executive director at chemical and pharmaceutical business Aventis/Rhône-Poulenc where at different times he oversaw the specialty chemicals, animal health and plant health divisions.
More on People
CapMan Managing Partner Johan Pålsson to depart
PУЅlsson resigns from management effective immediately; to stay as buyout partner until February 2024
Capvis grapples with EUR 1bn fundraise amid team exodus
Five partners for the Swiss-based GP leave firm in last two years; sponsor started sixth buyout fundraise in early 2023
Golding adds insurance expertise with hire for institutional clients team
Tim Ickenroth joins as director with prior experience at BNP Paribas and UniCredit
Travers Smith bolsters funds practice with hire from Proskauer
Tosin Adeyeri joins with particular experience in secondary portfolio transactions
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds